Activated Signaling Pathways and Targeted Therapies in Desmoid-Type Fibromatosis: A Literature Review
出版年份 2019 全文链接
标题
Activated Signaling Pathways and Targeted Therapies in Desmoid-Type Fibromatosis: A Literature Review
作者
关键词
-
出版物
Frontiers in Oncology
Volume 9, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2019-05-17
DOI
10.3389/fonc.2019.00397
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Gastrointestinal stromal tumours: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up†
- (2018) P G Casali et al. ANNALS OF ONCOLOGY
- Systematic Review of Clinical Outcomes Following Various Treatment Options for Patients with Extraabdominal Desmoid Tumors
- (2018) Kortnye Smith et al. ANNALS OF SURGICAL ONCOLOGY
- Sorafenib inhibits proliferation and invasion in desmoid-derived cells by targeting Ras/MEK/ERK and PI3K/Akt/mTOR pathways
- (2018) Laura Rosenberg et al. CARCINOGENESIS
- Wnt signaling in development and tissue homeostasis
- (2018) Zachary Steinhart et al. DEVELOPMENT
- Novel intra-genic large deletions of CTNNB1 gene identified in WT desmoid-type fibromatosis
- (2018) Chiara Colombo et al. GENES CHROMOSOMES & CANCER
- Pazopanib therapy for desmoid tumors in adolescent and young adult patients
- (2018) Laura Agresta et al. PEDIATRIC BLOOD & CANCER
- Sorafenib for Advanced and Refractory Desmoid Tumors
- (2018) Mrinal M. Gounder et al. NEW ENGLAND JOURNAL OF MEDICINE
- Imatinib induces sustained progression arrest in RECIST progressive desmoid tumours: Final results of a phase II study of the German Interdisciplinary Sarcoma Group (GISG)
- (2017) Bernd Kasper et al. EUROPEAN JOURNAL OF CANCER
- Surgical versus non-surgical approach in primary desmoid-type fibromatosis patients: A nationwide prospective cohort from the French Sarcoma Group
- (2017) Nicolas Penel et al. EUROPEAN JOURNAL OF CANCER
- Dermatofibrosarcoma protuberans and gastrointestinal stromal tumor as models for targeted therapy in soft tissue sarcomas
- (2017) Hanna Koseła-Paterczyk et al. Expert Review of Anticancer Therapy
- TALENs and CRISPR/Cas9 fuel genetically engineered clinically relevantXenopus tropicalistumor models
- (2017) Thomas Naert et al. GENESIS
- Clinical Activity of the γ-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors (Aggressive Fibromatosis)
- (2017) Shivaani Kummar et al. JOURNAL OF CLINICAL ONCOLOGY
- Genotype-phenotype correlation ofCTNNB1mutations reveals different ß-catenin activity associated with liver tumor progression
- (2016) Sandra Rebouissou et al. HEPATOLOGY
- AKT1andBRAFmutations in pediatric aggressive fibromatosis
- (2016) Cristina Meazza et al. Cancer Medicine
- Time Trends in the Incidence and Treatment of Extra-Abdominal and Abdominal Aggressive Fibromatosis: A Population-Based Study
- (2015) Danique L. M. van Broekhoven et al. ANNALS OF SURGICAL ONCOLOGY
- The JAK-STAT Pathway: Impact on Human Disease and Therapeutic Intervention
- (2015) John J. O'Shea et al. Annual Review of Medicine
- Targeting theNotch pathway: A potential therapeutic approach for desmoid tumors
- (2015) Hui Shang et al. CANCER
- Notch signaling: An emerging therapeutic target for cancer treatment
- (2015) Xun Yuan et al. CANCER LETTERS
- Sporadic extra abdominal wall desmoid-type fibromatosis: Surgical resection can be safely limited to a minority of patients
- (2015) C. Colombo et al. EUROPEAN JOURNAL OF CANCER
- Near universal detection of alterations inCTNNB1and Wnt pathway regulators in desmoid-type fibromatosis by whole-exome sequencing and genomic analysis
- (2015) Aimee M. Crago et al. GENES CHROMOSOMES & CANCER
- Constitutive activation of STAT3 in breast cancer cells: A review
- (2015) Kasturi Banerjee et al. INTERNATIONAL JOURNAL OF CANCER
- Targeting Notch, Hedgehog and Wnt pathways in cancer stem cells: clinical update
- (2015) Naoko Takebe et al. Nature Reviews Clinical Oncology
- Treatment of Aggressive Pelvic Fibromatosis With Interferon
- (2015) Femke Ariën et al. OBSTETRICS AND GYNECOLOGY
- Pediatric phase I trial of oral sorafenib and topotecan in refractory or recurrent pediatric solid malignancies
- (2015) Damon R. Reed et al. Cancer Medicine
- Targeting Stem Cell Behavior in Desmoid Tumors (Aggressive Fibromatosis) by Inhibiting Hedgehog Signaling
- (2015) Ronak Ghanbari-Azarnier et al. NEOPLASIA
- Prognostic Value of CTNNB1 Gene Mutation in Primary Sporadic Aggressive Fibromatosis
- (2014) Danique L. M. van Broekhoven et al. ANNALS OF SURGICAL ONCOLOGY
- Isolated limb perfusion using tumour necrosis factor α and melphalan in patients with advanced aggressive fibromatosis
- (2014) D. L. M. van Broekhoven et al. BRITISH JOURNAL OF SURGERY
- Percutaneous Image-Guided Cryoablation in Inoperable Extra-abdominal Desmoid Tumors: A Study of Tolerability and Efficacy
- (2014) M. Havez et al. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
- Wnt–Notch signalling crosstalk in development and disease
- (2014) Giovanna M. Collu et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- A Phase I, Dose-Finding Study in Patients with Advanced Solid Malignancies of the Oral -Secretase Inhibitor PF-03084014
- (2014) W. A. Messersmith et al. CLINICAL CANCER RESEARCH
- A prospective multicenter phase II study of sunitinib in patients with advanced aggressive fibromatosis
- (2014) Jae-Cheol Jo et al. INVESTIGATIONAL NEW DRUGS
- The Multifaceted Roles of STAT3 Signaling in the Progression of Prostate Cancer
- (2014) Jennifer Bishop et al. Cancers
- A Prognostic Nomogram for Prediction of Recurrence in Desmoid Fibromatosis
- (2013) Aimeé M. Crago et al. ANNALS OF SURGERY
- Spontaneous Regression of Primary Abdominal Wall Desmoid Tumors: More Common than Previously Thought
- (2013) Sylvie Bonvalot et al. ANNALS OF SURGICAL ONCOLOGY
- CTNNB1 45F mutation is a molecular prognosticator of increased postoperative primary desmoid tumor recurrence
- (2013) Chiara Colombo et al. CANCER
- Complex Reconstruction of Desmoid Tumor Resections Does Not Increase Desmoid Tumor Recurrence
- (2013) Patrick B. Garvey et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- The mechanisms of Hedgehog signalling and its roles in development and disease
- (2013) James Briscoe et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- -Catenin Mutation Status and Outcomes in Sporadic Desmoid Tumors
- (2013) J. T. Mullen et al. ONCOLOGIST
- Safety and efficacy of high-dose tamoxifen and sulindac for desmoid tumor in children: Results of a Children's Oncology Group (COG) Phase II Study
- (2013) Stephen X. Skapek et al. PEDIATRIC BLOOD & CANCER
- Targeting Notch signaling pathway in cancer: Clinical development advances and challenges
- (2013) Naoko Takebe et al. PHARMACOLOGY & THERAPEUTICS
- Triparanol suppresses human tumor growth in vitro and in vivo
- (2012) Xinyu Bi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Signal transduction pathway analysis in desmoid-type fibromatosis: Transforming growth factor-β, COX2 and sex steroid receptors
- (2012) Nicholas A. Mignemi et al. CANCER SCIENCE
- Molecular Pathways: Context-Dependent Approaches to Notch Targeting as Cancer Therapy
- (2012) A. M. Egloff et al. CLINICAL CANCER RESEARCH
- Signal transduction pathway analysis in fibromatosis: receptor and nonreceptor tyrosine kinases
- (2012) Justin M.M. Cates et al. HUMAN PATHOLOGY
- Phase I Pharmacologic and Pharmacodynamic Study of the Gamma Secretase (Notch) Inhibitor MK-0752 in Adult Patients With Advanced Solid Tumors
- (2012) Ian Krop et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I Study of RO4929097, a Gamma Secretase Inhibitor of Notch Signaling, in Patients With Refractory Metastatic or Locally Advanced Solid Tumors
- (2012) Anthony W. Tolcher et al. JOURNAL OF CLINICAL ONCOLOGY
- CTNNB1 mutation analysis is a useful tool for the diagnosis of desmoid tumors: a study of 260 desmoid tumors and 191 potential morphologic mimics
- (2012) Sophie Le Guellec et al. MODERN PATHOLOGY
- TGFβ signalling in context
- (2012) Joan Massagué NATURE REVIEWS MOLECULAR CELL BIOLOGY
- A High Throughput Screen Identifies Nefopam as Targeting Cell Proliferation in β-Catenin Driven Neoplastic and Reactive Fibroproliferative Disorders
- (2012) Raymond Poon et al. PLoS One
- Chemotherapy in patients with desmoid tumors: a study from the French Sarcoma Group (FSG)
- (2011) D. Garbay et al. ANNALS OF ONCOLOGY
- Colorectal cancers choosing sides
- (2011) Cristina Albuquerque et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Mesenchymal Stromal Cell Mutations and Wound Healing Contribute to the Etiology of Desmoid Tumors
- (2011) A. M. Carothers et al. CANCER RESEARCH
- Akt signalling in health and disease
- (2011) Ingeborg Hers et al. CELLULAR SIGNALLING
- Anti-oestrogen therapy in the treatment of desmoid tumours: a systematic review
- (2011) D. Bocale et al. Colorectal Disease
- Abnormalities of the Wnt/β-catenin signalling pathway induce tumour progression in sporadic desmoid tumours: correlation between β-catenin widespread nuclear expression and VEGF overexpression
- (2011) Hiroshi Matono et al. HISTOPATHOLOGY
- Notch3 signalling promotes tumour growth in colorectal cancer
- (2011) Valentina Serafin et al. JOURNAL OF PATHOLOGY
- Advanced aggressive fibromatosis: Effective palliation with chemotherapy
- (2010) Anastasia Constantinidou et al. ACTA ONCOLOGICA
- Imatinib for progressive and recurrent aggressive fibromatosis (desmoid tumors): an FNCLCC/French Sarcoma Group phase II trial with a long-term follow-up
- (2010) N. Penel et al. ANNALS OF ONCOLOGY
- Identification of biological factors predictive of response to imatinib mesylate in aggressive fibromatosis
- (2010) A Dufresne et al. BRITISH JOURNAL OF CANCER
- High frequency of β-catenin heterozygous mutations in extra-abdominal fibromatosis: a potential molecular tool for disease management
- (2010) J Dômont et al. BRITISH JOURNAL OF CANCER
- Aggressive Fibromatosis (Desmoid Tumor) Is Derived from Mesenchymal Progenitor Cells
- (2010) C. Wu et al. CANCER RESEARCH
- Efficacy of Imatinib in Aggressive Fibromatosis: Results of a Phase II Multicenter Sarcoma Alliance for Research through Collaboration (SARC) Trial
- (2010) R. Chugh et al. CLINICAL CANCER RESEARCH
- Potential for functional redundancy in EGF and TGFα signaling in desmoid cells: a cDNA microarray analysis
- (2010) Sylvia H. Trang et al. GROWTH FACTORS
- Desmoid-Type Fibromatosis: A Front-Line Conservative Approach to Select Patients for Surgical Treatment
- (2009) Marco Fiore et al. ANNALS OF SURGICAL ONCOLOGY
- Dissecting the role of mTOR: Lessons from mTOR inhibitors
- (2009) Ryan J.O. Dowling et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Human colon cancer epithelial cells harbour active HEDGEHOG-GLI signalling that is essential for tumour growth, recurrence, metastasis and stem cell survival and expansion
- (2009) Frédéric Varnat et al. EMBO Molecular Medicine
- Multicenter Phase II Trial of Sunitinib in the Treatment of Nongastrointestinal Stromal Tumor Sarcomas
- (2009) Suzanne George et al. JOURNAL OF CLINICAL ONCOLOGY
- Desmoid cell motility is induced in vitro by rhEGF
- (2009) David E. Joyner et al. JOURNAL OF ORTHOPAEDIC RESEARCH
- Early experience with percutaneous cryoablation of extra-abdominal desmoid tumors
- (2009) Jennifer L. Kujak et al. SKELETAL RADIOLOGY
- Specific Mutations in the β-Catenin Gene (CTNNB1) Correlate with Local Recurrence in Sporadic Desmoid Tumors
- (2008) Alexander J.F. Lazar et al. AMERICAN JOURNAL OF PATHOLOGY
- Phase II, Open-Label Study Evaluating the Activity of Imatinib in Treating Life-Threatening Malignancies Known to Be Associated with Imatinib-Sensitive Tyrosine Kinases
- (2008) M. C. Heinrich et al. CLINICAL CANCER RESEARCH
- The role of APC and beta-catenin in the aetiology of aggressive fibromatosis (desmoid tumors)
- (2008) D.J. Lips et al. EJSO
- Correlation between β-catenin widespread nuclear expression and matrix metalloproteinase-7 overexpression in sporadic desmoid tumors
- (2008) Hiroshi Matono et al. HUMAN PATHOLOGY
- The role of PTEN signaling perturbations in cancer and in targeted therapy
- (2008) M Keniry et al. ONCOGENE
- Toremifene decreases type I, type II and increases type III receptors in desmoid and fibroma and inhibits TGFbeta1 binding in desmoid fibroblasts
- (2007) Giordano Stabellini et al. BIOMEDICINE & PHARMACOTHERAPY
- Extra-abdominal primary fibromatosis: Aggressive management could be avoided in a subgroup of patients
- (2007) S. Bonvalot et al. EJSO
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now